This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should Progressive Be in Your Portfolio Post Q3 Earnings?
by Tanuka De
PGR seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
Brokers Suggest Investing in Allstate (ALL): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Allstate (ALL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Why Allstate (ALL) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Has Camden Property Trust (CPT) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Camden (CPT) and Allstate (ALL) have performed compared to their sector so far this year.
The Allstate Corporation (ALL) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Allstate (ALL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Allstate Acquires Kingfisher, Enhances Mobile Industry Offerings
by Zacks Equity Research
ALL's acquisition of Kingfisher bodes well. The acquisition aids in the enhancement of the company's Protection Plans offerings for smart devices.
Allstate (ALL) Laps the Stock Market: Here's Why
by Zacks Equity Research
Allstate (ALL) closed the most recent trading day at $190.53, moving +1.2% from the previous trading session.
Here's Why Allstate (ALL) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Progressive Stock Be in Your Portfolio Ahead of Q3 Earnings?
by Tanuka De
PGR's third-quarter earnings are likely to have benefited from improved rates, solid policies in force and higher retention in its Vehicle and Property businesses.
Allstate (ALL) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Allstate (ALL) closed at $182.87 in the latest trading session, marking a +0.89% move from the prior day.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Will Allstate (ALL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Allstate (ALL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Retain Allstate Stock in Your Portfolio Now?
by Zacks Equity Research
ALL is set to benefit from improving premiums, enhanced distribution strategies and cost control efforts.
Why Allstate (ALL) Outpaced the Stock Market Today
by Zacks Equity Research
Allstate (ALL) closed the most recent trading day at $189.65, moving +0.68% from the previous trading session.
4 Low-Beta P&C Insurance Stocks to Hedge Against Market Uncertainty
by Sushmita Sarker
Here, we discuss four low-beta stocks, ALL, AXS, PGR and WRB, which boast strong growth potential and are poised to deliver steady performance.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PRI Near 52-Week High: Should You Add the Stock to Your Portfolio Now?
by Zacks Equity Research
Primerica's strong licensed sales force, ensuring sales growth and policy persistency, and decision to exit the senior health market poise it well for growth.
Why Allstate (ALL) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Allstate (ALL) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Allstate (ALL) stood at $191.82, denoting a -0.55% change from the preceding trading day.
BRK.B Stock Trading In Line With the Industry at 1.61X: Buy or Hold?
by Tanuka De
Given that Berkshire shares are now trading in line with the industry average, it is wise to add this company to your portfolio.
Allstate's July & Aug CAT Loss Hits $814M, Stock Reaches 52-Week High
by Zacks Equity Research
ALL continues to benefit from strategic rate increases, higher market-based investment income and growing insurance premiums.
Chubb Stock Trading Near 52-Week High: What Should Investors Know?
by Zacks Equity Research
CB's market-leading position, strategic initiatives, solid capital position and better return on capital pave the way for long-term growth.
Why the Market Dipped But Allstate (ALL) Gained Today
by Zacks Equity Research
Allstate (ALL) closed at $191.01 in the latest trading session, marking a +0.39% move from the prior day.
Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?
by Zacks Equity Research
Sector ETF report for KBWP